Open AccessCOVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins
Author(s) -
N. S. Stuleva,
А. Л. Мищенко
Publication year - 2021
Publication title -
akušerstvo, ginekologiâ i reprodukciâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.124
H-Index - 4
eISSN - 2500-3194
pISSN - 2313-7347
DOI - 10.17749/2313-7347/ob.gyn.rep.2021.219
Subject(s) - medicine , covid-19 , assisted reproductive technology , low birth weight , low molecular weight heparin , pregnancy , obstetrics , heparin , virology , infertility , disease , biology , outbreak , infectious disease (medical specialty) , genetics
We have accumulated my own experience of management pregnant women with COVID-19 after assisted reproductive technologies (ART) receiving low molecular weight heparins (LMWH). All women suffered COVID-19 in mild form without respiratory failure and gave birth to healthy children. Our observations correspond to the data of world literature. Therefore, we want to draw the attention of the editors and the readers to the positive role of LMWH in the control of COVID-19.